-
1
-
-
0028880443
-
Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis
-
Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995;333:1600-1607.
-
(1995)
N Engl J Med
, vol.333
, pp. 1600-1607
-
-
Roujeau, J.C.1
Kelly, J.P.2
Naldi, L.3
-
2
-
-
15244341936
-
Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: A case-control study
-
Lin MS, Dai YS, Pwu RF, Chen YH, Chang NC. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study. Intern Med J. 2005;35:188-190.
-
(2005)
Intern Med J
, vol.35
, pp. 188-190
-
-
Lin, M.S.1
Dai, Y.S.2
Pwu, R.F.3
Chen, Y.H.4
Chang, N.C.5
-
3
-
-
0017187913
-
Erythema multiforme in children: Response to treatment with systemic corticosteroids
-
Rasmussen JE. Erythema multiforme in children: response to treatment with systemic corticosteroids. Br J Dermatol. 1976;95:181-186.
-
(1976)
Br J Dermatol
, vol.95
, pp. 181-186
-
-
Rasmussen, J.E.1
-
4
-
-
0024432618
-
Corticosteroids for erythema multiforme?
-
Corticosteroids for erythema multiforme? Pediatr Dermatol. 1989;6:229-250.
-
(1989)
Pediatr Dermatol
, vol.6
, pp. 229-250
-
-
-
5
-
-
0022980214
-
Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids
-
Halebian PH, Corder VJ, Madden MR, Finklestein JL, Shires GT. Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg. 1986;204:503-512. (Pubitemid 17176768)
-
(1986)
Annals of Surgery
, vol.204
, Issue.5
, pp. 503-512
-
-
Halebian, P.H.1
Madden, M.R.2
Finklestein, J.L.3
-
6
-
-
0032538505
-
Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
-
DOI 10.1126/science.282.5388.490
-
Viard I, Wehrli P, Bullani R, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science. 1998;282:490-493. (Pubitemid 28483679)
-
(1998)
Science
, vol.282
, Issue.5388
, pp. 490-493
-
-
Viard, I.1
Wehrli, P.2
Bullani, R.3
Schneider, P.4
Holler, N.5
Salomon, D.6
Hunziker, T.7
Saurat, J.-H.8
Tschopp, J.9
French, L.E.10
-
7
-
-
0037231873
-
Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami experience
-
DOI 10.1001/archderm.139.1.39
-
Trent JT, Kirsner RS, Romanelli P, Kerdel FA. Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: the University of Miami experience. Arch Dermatol. 2003;139:39-43. (Pubitemid 36091572)
-
(2003)
Archives of Dermatology
, vol.139
, Issue.1
, pp. 39-43
-
-
Trent, J.T.1
Kirsner, R.S.2
Romanelli, P.3
Kerdel, F.A.4
-
8
-
-
0346850814
-
Use of Intravenous Immunoglobulin in Children with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Seven Cases and Review of the Literature
-
DOI 10.1542/peds.112.6.1430
-
Metry DW, Jung P, Levy ML. Use of intravenous immunoglobulin in children with Stevens-Johnson syndrome and toxic epidermal necrolysis: seven cases and review of the literature. Pediatrics. 2003;112:1430-1436. (Pubitemid 37523435)
-
(2003)
Pediatrics
, vol.112
, Issue.6 I
, pp. 1430-1436
-
-
Metry, D.W.1
Jung, P.2
Levy, M.L.3
|